New Delhi: With an aim to launch vaccine forInfluenza H1N1 A Virus (swine flu) in India, CadilaPharmaceutical will seek the government`s nod in two days forinitiating clinical trials in this regard.Cadila Pharmaceutical Ltd (CPL) had set up a jointventure `CPL Biologicals Pvt Ltd` with the US-based vaccinemaker Novavax for manufacturing and developing a host ofvaccines, including for swine flu, in India.
Narendra Modi flies to Brazil for BRICS Summit
Dilip Kumar`s ancestral home declared national heritage in Pak
Govt prepares list of five governors for Raj Bhawans
UPSC aspirants protest outside Rajnath Singh`s residence